These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 25734445)

  • 1. Later cART initiation in migrant men from sub-Saharan Africa without advanced HIV disease in France.
    de Monteynard LA; Dray-Spira R; de Truchis P; Grabar S; Launay O; Meynard JL; Khuong-Josses MA; Gilquin J; Rey D; Simon A; Pavie J; Mahamat A; Matheron S; Costagliola D; Abgrall S;
    PLoS One; 2015; 10(3):e0118492. PubMed ID: 25734445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of geographic origin, sex, and HIV transmission group on the outcome of first-line combined antiretroviral therapy in France.
    de Monteynard LA; Matheron S; Gilquin J; Pavie J; de Truchis P; Grabar S; Launay O; Meynard JL; Khuong-Josses MA; Rey D; Simon A; Mahamat A; Dray-Spira R; Costagliola D; Abgrall S;
    AIDS; 2016 Sep; 30(14):2235-46. PubMed ID: 27428741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of geographic origin on AIDS and serious non-AIDS morbidity/mortality during cART among heterosexual HIV-infected men and women in France.
    de Monteynard LA; Matheron S; Grabar S; de Truchis P; Gilquin J; Pavie J; Launay O; Meynard JL; Khuong-Josses MA; Rey D; Mahamat A; Dray-Spira R; Simon A; Costagliola D; Abgrall S;
    PLoS One; 2018; 13(10):e0205385. PubMed ID: 30379870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does region of origin influence the timing and outcome of first-line antiretroviral therapy in France?
    Gatey C; Brun A; Hamet G; Diamantis S; Sellier P; Bouchaud O; Garrait V; Rozenbaum W; Molina JM; Abgrall S;
    HIV Med; 2019 Feb; 20(2):175-181. PubMed ID: 30506853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics and response to antiretroviral therapy of HIV-1-infected patients born in Africa and living in France.
    Breton G; Lewden C; Spire B; Salmon D; Brun-Vézinet F; Duong M; Allavena C; Leport C; Salamon R;
    HIV Med; 2007 Apr; 8(3):164-70. PubMed ID: 17461860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sub-Saharan African migrants have slower initial CD4+ cell recovery after combined antiretroviral treatment initiation than French natives.
    Seng R; Ghislain M; Girard PM; Cotte L; Meybeck A; Raffi F; Abgrall S; Yazdanpanah Y; Goujard C; Dray-Spira R; Meyer L
    AIDS; 2017 Jun; 31(9):1323-1332. PubMed ID: 28492394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4-cell counts and presence of AIDS in HIV-positive patients entering specialized care-a comparison of migrant groups in the German ClinSurv HIV Cohort Study, 1999-2013.
    Zeitlmann N; Gunsenheimer-Bartmeyer B; Santos-Hövener C; Kollan C; An der Heiden M;
    BMC Infect Dis; 2016 Dec; 16(1):739. PubMed ID: 27927190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Timing of combined antiretroviral treatment initiation in male and female migrants living with HIV in Western Europe.
    Migrant Health Working Group for the Collaboration of Observational HIV Epidemiological Research in Europe (COHERE) in EuroCoord
    AIDS; 2017 Mar; 31(6):835-846. PubMed ID: 28272136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated risk of viral rebound on ART in migrants living in France: role of socioeconomic factors.
    Abgrall S; Raho-Moussa M; Seng R; Ghislain M; Matheron S; Pialoux G; Goujard C; Meyer L;
    Antivir Ther; 2019; 24(7):541-552. PubMed ID: 31868654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and impact of hepatitis B and C virus co-infections in antiretroviral treatment naïve patients with HIV infection at a major treatment center in Ghana.
    Sagoe KW; Agyei AA; Ziga F; Lartey M; Adiku TK; Seshi M; Arens MQ; Mingle JA
    J Med Virol; 2012 Jan; 84(1):6-10. PubMed ID: 22095533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-associated Isospora belli infection: incidence and risk factors in the French Hospital Database on HIV.
    Guiguet M; Furco A; Tattevin P; Costagliola D; Molina JM;
    HIV Med; 2007 Mar; 8(2):124-30. PubMed ID: 17352769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [National consensus document by GESIDA/National Aids Plan on antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2011 update)].
    Panel de expertos de GESIDA y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2011 Mar; 29(3):209.e1-103. PubMed ID: 21388714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased risk of virologic failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: data from the ICONA cohort.
    Saracino A; Lorenzini P; Lo Caputo S; Girardi E; Castelli F; Bonfanti P; Rusconi S; Caramello P; Abrescia N; Mussini C; Monno L; d'Arminio Monforte A;
    Clin Microbiol Infect; 2016 Mar; 22(3):288.e1-8. PubMed ID: 26551839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inequalities in HIV disease management and progression in migrants from Latin America and sub-Saharan Africa living in Spain.
    Monge S; Alejos B; Dronda F; Del Romero J; Iribarren JA; Pulido F; Rubio R; Miró JM; Gutierrez F; Del Amo J;
    HIV Med; 2013 May; 14(5):273-83. PubMed ID: 23171059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of non-AIDS-defining events among HIV-infected patients not yet on antiretroviral therapy.
    Zhang S; van Sighem A; Kesselring A; Gras L; Prins JM; Hassink E; Kauffmann R; Richter C; de Wolf F; Reiss P;
    HIV Med; 2015 May; 16(5):265-72. PubMed ID: 25604160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Travel-related health events and their risk factors in HIV-infected sub-Saharan migrants living in France and visiting their native country: The ANRS VIHVO cohort study.
    Pistone T; Ouattara E; Gabillard D; Lele N; Duvignaud A; Cordel H; Malvy D; Bouchaud O; Abgrall S;
    Travel Med Infect Dis; 2019; 29():40-47. PubMed ID: 30951905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological and virological response to antiretroviral treatment in migrant and native men and women in Western Europe; is benefit equal for all?
    Migrant Health Working Group for the Collaboration of Observational HIV Epidemiological Research in Europe (COHERE) in EuroCoord
    HIV Med; 2018 Jan; 19(1):42-48. PubMed ID: 28741837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [HIV infection in immigrants in Spain: Epidemiological characteristics and clinical presentation in the CoRIS Cohort (2004-2006)].
    Caro-Murillo AM; Gutiérrez F; Manuel Ramos J; Sobrino P; Miró JM; López-Cortés LF; Tural C; Moreno A; de Los Santos I; Murillas J; Camino X; Salavert M; Rubio R; Moreno S; del Amo J;
    Enferm Infecc Microbiol Clin; 2009; 27(7):380-8. PubMed ID: 19427080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of HIV-related anal cancer remains increased despite long-term combined antiretroviral treatment: results from the french hospital database on HIV.
    Piketty C; Selinger-Leneman H; Bouvier AM; Belot A; Mary-Krause M; Duvivier C; Bonmarchand M; Abramowitz L; Costagliola D; Grabar S
    J Clin Oncol; 2012 Dec; 30(35):4360-6. PubMed ID: 23091098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Consensus document of Gesida and Spanish Secretariat for the National Plan on AIDS (SPNS) regarding combined antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2012)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2012 Jun; 30(6):e1-89. PubMed ID: 22633764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.